ABC Communications
- ABC Comments to the FDA on Draft Guidance for Industry "Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials”
June 13, 2022 - Organizational Letter to Energy & Commerce Committee in “Support of the NIH Clinical Trial Diversity Act”
June 9, 2022
- ABC Letter to Rep. Eshoo on the “Diverse and Equitable Participation in Clinical Trials (DEPICT) Act”
July 19, 2021
Resources
- Rep. Robin Kelly Press Release on Introduction of the “NIH Clinical Trial Diversity Act” with ABC Endorsement and Quote from Dr. Michelle Albert
May 19, 2022 - NIH Clinical Trial Diversity Act of 2022 (H.R. 7845) ✓ABC Endorsed
- Rep. Anna Eshoo Press Release on Committee Consideration of the “Diverse and Equitable Participation in Clinical Trails (DEPICT) Act”
May 18, 2022
- Rep. Anna Eshoo Press Statement on New FDA Guidance for Diversity in Clinical Trials
April 13, 2022 - FDA Draft Guidance: Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials Guidance for Industry
April 13, 2022
February 3, 2022